Scarica l'app Stockscreener
59.18
0.45%
-0.265
Tempus Ai Inc Borsa (TEM) Ultime notizie
TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of - Bluefield Daily Telegraph
TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS - GlobeNewswire
TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Tempus AI (NASDAQ:TEM) Stock Price Up 1.2%Time to Buy? - MarketBeat
INVESTOR ALERT: Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead the Tempus AI Class Action LawsuitTEM - PR Newswire
TEMPUS AI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY - GlobeNewswire
TEMPUS AI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC - Bluefield Daily Telegraph
TEM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Tempus AI, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Tempus AI (TEM) Stock Skyrockets Over 13% on Strong Investor Demand - Daily Chhattisgarh News
Aspiriant LLC Makes New $661,000 Investment in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus to Participate in TD Cowen’s 4th Annual Tools/Dx Revolution Conference - BioSpace
Tempus AI (NASDAQ:TEM) Trading Down 1.6%Should You Sell? - MarketBeat
Rakuten Securities Inc. Boosts Stake in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Nancy Pelosi is up 130% on this stock since January - Finbold
Exchange Traded Concepts LLC Has $4.30 Million Stock Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Day 7 of Gains Streak for Tempus AI Stock with 23% Return (vs. 113% YTD) [6/16/2025] - Trefis
TEMPUS AI SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc.TEM | FinancialContent - FinancialContent
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Tempus AI, Inc. (TEM) - TradingView
Tempus AI (NASDAQ:TEM) Trading 3% HigherTime to Buy? - MarketBeat
Tempus AI Inc (TEM) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Bullish flow in tempus AI Inc Class A with shares up 1.33% - TipRanks
TEM Investors Have Opportunity to Lead Tempus AI, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Tempus AI (TEM) Stock Soars, Highlighting Massive Investor Confidence in Precision Medicine - Daily Chhattisgarh News
TEMPUS AI, INC. (NASDAQ: TEM) INVESTOR ALERT Investors With - GlobeNewswire
Tempus AI, Inc. (NASDAQ:TEM) Director Theodore Leonsis Sells 205,847 Shares - MarketBeat
Why Shares of Tempus AI Are Jumping Higher This Week - AOL.com
Avanza Fonder AB Has $2.05 Million Holdings in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Medical Stocks To Follow Now – June 13th - Defense World
Tempus AI (NASDAQ:TEM) Trading 1.4% HigherWhat's Next? - MarketBeat
Tempus AI (NasdaqGS:TEM) Soars 51% In Last Quarter - Yahoo Finance
TEM Investor Notice: Robbins LLP Reminds Shareholders of - GlobeNewswire
TEM Investor News: If You Have Suffered Losses in Tempus - GlobeNewswire
Artificial Intelligence Stocks To Follow Now – June 12th - Defense World
TEMPUS ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
TEM Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against ... - Eagle-Tribune
TEM Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Tempus AI, Inc. Class Action - GlobeNewswire Inc.
Health Tech Co. Overstated AI Capabilities, Investor Suit Says - Law360
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are ... - Eagle-Tribune
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - TradingView
Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach - sharewise
Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025 - GlobeNewswire
Tempus AI Stock (TEM) Jumps 2.41% to $72.95, Capping a Week of Strong Gains - Daily Chhattisgarh News
Tempus Investor Sues Over Short Seller’s AI, CEO Accusations (1) - Bloomberg Law News
Shareholders Filed a Lawsuit Against Tempus AI for Inflating Its IPO Valuation - TradingView
Tempus AI Insiders Made A Wise Decision By Selling US$342m Worth Of Stock - simplywall.st
Tempus AI ($TEM) IPO Misrepresentations, Weak Financials, and Investor Deception Case - TradingView
Shareholder Alert: Robbins LLP Informs Investors of the Tempus AI, Inc. Class Action - Kilgore News Herald
Top Artificial Intelligence Stocks To Watch Now – June 11th - Defense World
Medical Stocks To Research – June 11th - Defense World
Tempus AI teams with Northwestern to advance Alzheimer’s research By Investing.com - Investing.com South Africa
Veteran analyst unveils bold price target for Tempus AI stock - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Tempus, Northwestern partner to focus AI on Alzheimer's research - Crain's Chicago Business
Tempus AI (TEM) Stock Surges Over 100% Year-to-Date Amid Strong Momentum - Daily Chhattisgarh News
Tempus, Northwestern Collaborate on AI-Driven Alzheimer's Research - marketscreener.com
Tempus AI, Inc. Announces Collaboration with Northwestern University's Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer's Disease Research - MarketScreener
Tempus AI teams with Northwestern to advance Alzheimer’s research - Investing.com Australia
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc.TEM - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc.TEM - PR Newswire
Tempus Announces Collaboration With Northwestern University's Abrams Research Center On Neurogenomics - marketscreener.com
Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research - Yahoo Finance
1.59%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):